CLINICAL TRIAL / NCT01321073

DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study

  • Interventional
  • Active
  • NCT01321073

DelIVery for Pulmonary Arterial Hypertension (PAH) Clinical Study

The purpose of the DelIVery for PAH clinical study is to evaluate the safety of the Medtronic Model 10642 Implantable Intravascular Catheter when used with the Medtronic SynchroMed® II Implantable Infusion System to deliver Remodulin® (treprostinil) Injection. As of June 2021, PMA approval of the Implantable System for Remodulin (ISR) is no longer being pursued and development and commercialization efforts have been halted. The approximately 30 subjects still implanted with the PIVoT system require a pathway for continued support. This protocol is amended and is designed to allow such ongoing support.